Hung Ka Kung
Director/Board Member at ZERO2IPO HOLDINGS INC.
Hung Ka Kung active positions
Companies | Position | Start | End |
---|---|---|---|
ZERO2IPO HOLDINGS INC. | Director/Board Member | 28/05/2020 | - |
Vcanbio Cell & Gene Engineering Corp.
Vcanbio Cell & Gene Engineering Corp. Miscellaneous Commercial ServicesCommercial Services Vcanbio Cell & Gene Engineering Corp. develops and stores cord blood hematopoietic stem cells. | Chairman | 30/11/2018 | - |
Zero2ipo Consulting Group Co. Ltd. | Director/Board Member | 31/01/2017 | - |
Wealth Strategy Holding Ltd. | Director/Board Member | - | - |
Pan Asia Information Services Ltd. | Director/Board Member | 30/06/1994 | - |
Fortune Time Technology Ltd. | Chairman | 31/03/2002 | - |
Career history of Hung Ka Kung
Former positions of Hung Ka Kung
Companies | Position | Start | End |
---|---|---|---|
GENETRON HOLDINGS LIMITED | Founder | - | - |
Beijing Watchdata Technologies Co. Ltd. | Founder | - | - |
SHANGHAI FULLHAN MICROELECTRONICS CO., LTD. | Director/Board Member | 31/03/2013 | - |
Training of Hung Ka Kung
Huazhong University of Science & Technology | Undergraduate Degree |
Statistics
International
China | 7 |
Hong Kong | 4 |
Cayman Islands | 2 |
Operational
Director/Board Member | 5 |
Chairman | 2 |
Founder | 2 |
Sectoral
Finance | 2 |
Commercial Services | 2 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
ZERO2IPO HOLDINGS INC. | Finance |
SHANGHAI FULLHAN MICROELECTRONICS CO., LTD. | Electronic Technology |
Private companies | 7 |
---|---|
Vcanbio Cell & Gene Engineering Corp.
Vcanbio Cell & Gene Engineering Corp. Miscellaneous Commercial ServicesCommercial Services Vcanbio Cell & Gene Engineering Corp. develops and stores cord blood hematopoietic stem cells. | Commercial Services |
Zero2ipo Consulting Group Co. Ltd. | |
Wealth Strategy Holding Ltd. | |
Genetron Holdings Ltd.
Genetron Holdings Ltd. Medical/Nursing ServicesHealth Services Genetron Holdings, Ltd. engages in precision oncology. It provides cancer molecular profiling by using technologies in molecular biology and data science to transform cancer treatment. It products and services include diagnosis and monitoring through both LDT and IVD products. Its LDT portfolio consists of both specifically designed focused and comprehensive gene panel testing services. It also develops liver cancer early screening products. The company was founded by Si Zhen Wang, Hai Yan, and Wei Wu He in 2015 and is headquartered in Beijing, China. | Health Services |
Beijing Watchdata Technologies Co. Ltd. | |
Pan Asia Information Services Ltd. | |
Fortune Time Technology Ltd. |
- Stock Market
- Insiders
- Hung Ka Kung
- Experience